Exabis Library
Welcome to the e-CCO Library!
P637: Targeting mucosal healing: dose optimization of Vedolizumab in IBD patients with inadequate endoscopic response to standard dosing
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P638: BMS-986165, an oral selective tyrosine kinase 2 (TYK2) inhibitor, does not affect the pharmacokinetics of methotrexate in healthy subjects
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P638: Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path towards the implementation of telemedicine in Spain?
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P638: Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: a GETAID multicentre cohort study
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P638: Nutritional status in paediatric Crohn’s disease patients: Does exclusive enteral nutrition help?
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P638: Release of 5-aminosalicylic acid from mesalazine formulations: a novel dynamic dissolution model simulating gastrointestinal pH changes
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P639 Outcomes of a clinical psychology intervention in a UK IBD service
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P639: Epidemiology and patient burden of rectovaginal and anovaginal fistulas in patients with Crohn’s disease: A systematic review
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P639: Incidence and disease presentation of inflammatory bowel disease in Denmark: initial findings from a Copenhagen IBD Inception Cohort Study
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P639: Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P639: Percutaneous drainage vs surgery as definitive treatment for anastomotic leak after intestinal resection in patients with Crohn's disease.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P639: Switching from originator-infliximab to biosimilar-Infliximab in IBD-patients does not lead to significant changes in infliximab trough levels
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P639: Validation of the Quantum Blue® infliximab-level rapid test in clinical practice of patients with inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P640 Moderate to severe endoscopic inflammation is frequent after clinical remission in pediatric ulcerative colitis: A cause for disease extension and relapse?
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P640: Characteristics of elderly onset Inflammatory Bowel Disease in a cohort of Hispanics
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P640: Evaluation of dietetic services and the impact of diet on disease activity for patients with inflammatory bowel disease at Imperial College Healthcare NHS Trust
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P640: Incidence, prevalence, disease phenotype and maximal therapeutic step in Crohn’s disease patients in Western Hungary – a population-based study between 2007–2018, data from the Veszprem county cohort
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P640: Risk of post-operative complications among Crohn’s disease patients treated pre-operatively with vedolizumab. A matched case–control study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM